Portrait Galantos Pharma GmbH, which was founded in 2005, is developing innovative drugs for the treatment of neurodegenerative diseases and is focused on the improvement of marketed drugs and natural substances for the treatment of Alzheimer’s Disease. The company has raised a total of EUR 3.5 million in two financing rounds.
Top
Kontakt
Druckansicht
PDF-Ansicht
Firma weiterempfehlen
